Correlation Between CTi Biopharma and TG Therapeutics
Can any of the company-specific risk be diversified away by investing in both CTi Biopharma and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTi Biopharma and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CTi Biopharma Corp and TG Therapeutics, you can compare the effects of market volatilities on CTi Biopharma and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTi Biopharma with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTi Biopharma and TG Therapeutics.
Diversification Opportunities for CTi Biopharma and TG Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CTi and TGTX is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding CTi Biopharma Corp and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and CTi Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTi Biopharma Corp are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of CTi Biopharma i.e., CTi Biopharma and TG Therapeutics go up and down completely randomly.
Pair Corralation between CTi Biopharma and TG Therapeutics
If you would invest 3,074 in TG Therapeutics on September 12, 2024 and sell it today you would earn a total of 93.00 from holding TG Therapeutics or generate 3.03% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 4.55% |
Values | Daily Returns |
CTi Biopharma Corp vs. TG Therapeutics
Performance |
Timeline |
CTi Biopharma Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
TG Therapeutics |
CTi Biopharma and TG Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CTi Biopharma and TG Therapeutics
The main advantage of trading using opposite CTi Biopharma and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTi Biopharma position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.CTi Biopharma vs. Rigel Pharmaceuticals | CTi Biopharma vs. Fortress Biotech | CTi Biopharma vs. Reviva Pharmaceuticals Holdings | CTi Biopharma vs. Protalix Biotherapeutics |
TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |